INNOVEOX gets Charles Rosier as new Partner and TOTAL EP as first client - Afrik-news.com : Africa news, Maghreb news - The african daily newspaper
Charles Rosier and His Work Experiences
charles rosier (visitez ici) established five major principles (Client Focus, Global Thinking Presence, Long Term View, Meritocracy and Partnership and World-Class Governance) at BTG Pactual. He became the Managing Director of Goldman Sachs, which is a huge investment banking firm, from the year 2009 to 2010. BTG Pactual is an investment bank situated in Latin America, with whom Charles Rosier was a partner for years.
Charles Rosier’s Story
He is interested in lots of things like studies, extreme sports, managing environmentally-friendly activities and culture. In 1996, Charles Rosier startedhis profession at Lehman Brothers before later becoming a member of UBS Warburg Investment Bank. He then became the head of the finance department at Goldman Sachs Bank. Charles Rosier attended additional classes at Integrale for 2 years, this being his preparation for ESCP Europe. He didn’t settle for just one job but took other positions in the industry while an investment banker.
Charles Rosier: Educational Background
He became recognised as being an investment banker who had had plenty of experience, particularly in big organisations with whom he had held many positions. Gaining his scientific Baccalaureate degree (equal to A-levels in the UK), Charles Rosier was able to attend to further education. Charles Rosier completed his secondary schooling at Paris’s Fenelon Sainte-Marie in the year 1991.
In August 2010, Charles Rosier joined BTG Pactual. He became partners with an investment bank in Latin America: BTG Pactual. Charles Rosier was offered a job at Goldman Sachs in 1999. He became their Managing Director. There are approximately 2,500 personnel currently employed at BTG Pactual, which has 30 years of experience.
Health Related Projects
Charles Rosier’s first healthcare project was the Mapreg Drug project. Being one of his healthcare projects, he invested in Mapreg, a pharmaceutical company led by Professor Etienne Baulieu. Whilst in great need for additional funds in developing a new drug, Baulieu and his co-workers obtained financial support from his huge investment. The investment by Charles Rosier allowed them to do certain research and, because of that, he was given a specific profit-share.